黏液溶解促排剂在弥漫性泛细支气管炎治疗中的作用  

Effect of mucolytic chelating agents in treatment of diffuse panbronchiolitis

作　　者：黄晓云 吴少任 张小红 

机构地区：[1]广东省工人医院,广东广州510720

出　　处：《华夏医学》2015年第3期32-35,共4页Acta Medicinae Sinica

基　　金：广州市黄埔区科技基金应用基础研究资助项目(201229-16)

摘　　要：目的:掌握黏液溶解促排剂的特点,明确黏液溶解促排剂在弥漫性泛细支气管炎(DPB)治疗中的作用。方法:将弥漫性泛细支气管炎患者56例随机分为研究组和对照组,两组均使用抗炎、止咳、化痰,研究组在此基础上加用黏液溶解促排剂(标准桃金娘油丸)。结果:经3个月治疗后,研究组治愈率为25.0%,较对照组10.7%高(P<0.01)。结论:黏液溶解促排剂能提高弥漫性泛细支气管炎的疗效。Objective：To master the characteristics of mucolytic chelating agents,chelating agents mucolytic clear role in the treatment of DPB.Methods：56 cases of diffuse panbronchiolitis patients were randomly divided into study group and control group.The two groups were treated by anti inflammation,relieving cough and reducing sputum.Beside this,study group was given mucolytic eccritic（standard Myrtle oil pill）,the control group without.Results：After 3 month＇s treatment,the curative rate of the study group was 25.0%,higher than 10.7%of the control group（P〈0.01）.Conclusion：Mucolytic chelating agents can improve the efficacy in treatment of diffuse panbronchiolitis.

关 键 词：黏液溶解促排剂 弥漫性泛细支气管炎 标准桃金娘油丸 

分 类 号：R562.21[医药卫生—呼吸系统]